Scientific publications 

Verapamil deleterious effects in chronic renal failure

C. Vázquez (a), A. Huelmos (b), E. Alegría (b), P. Errasti (a), A. Purroy (a)
Departments of (a) Nephrology and (b) Cardiology, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain

Magazine: Nephron

Date: Oct 1, 1999

Cardiology Nephrology [SP]

Three hypertensive patients with chronic renal failure treated with slow-release verapamil at the recommended doses for high blood pressure experienced acute deleterious effects shortly after treatment (6 h to 3 days). Patients developed slow cardiac rhythms (junctional bradycardia or atrial fibrillation), hypotension and hyperkalemia.

Consequently they also had oliguria and worsening of the renal function. Inotropic support, fluid therapy and potassium-lowering measures were able to restore the renal function and sinus rhythm after 10-12 h.

Only 7 similar cases have been described so far. It is suggested that slow-release formulations of verapamil must be used with caution in hypertensive patients with impaired renal function.

CITATION  Nephron. 1996;72(3):461-4

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra